Menu

VRBPAC Meetings

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRPBAC) members review and evaluate data concerning the safety, effectiveness and appropriate use of vaccines and related biological products which are intended for use in the prevention, treatment or diagnosis of human diseases, and, as required, any other products for which the U.S. Food and Drug Administration has regulatory responsibility. Find out more from our Live Blogs:


FDA VRBPAC Meeting, June 28, 2022 — Meryl Nass, M.D.
FDA VRBPAC Meeting, Day 2, June 15, 2022 — Meryl Nass, M.D.
FDA VRBPAC Meeting Day 1, June 14, 2022 — Meryl Nass, M.D.

LEGAL DISCLAIMER